Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 91 of 1714:
81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101
Gene Compound Assay Inh Ic50 Ki View
adrenergic receptor, beta 2 TERBUTALINE Adrenergic beta2 55% NoneNone NoneNone View
phosphodiesterase 4A, cAMP specific NIFEDIPINE Phosphodiesterase PDE4 55% 44.158uM NoneNone View
phosphodiesterase 4C, cAMP-specific NIFEDIPINE Phosphodiesterase PDE4 55% 44.158uM NoneNone View
phosphodiesterase 4D NIFEDIPINE Phosphodiesterase PDE4 55% 44.158uM NoneNone View
phosphodiesterase 4B, cAMP specific NIFEDIPINE Phosphodiesterase PDE4 55% 44.158uM NoneNone View
adrenergic receptor, alpha 2b ERGONOVINE Adrenergic alpha2C 55% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) ERGONOVINE Adrenergic alpha2C 55% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B TETRACAINE Serotonin 5-HT2B 55% NoneNone NoneNone View
aldo-keto reductase family 1, member B4 (aldose reductase) CITRININ Aldose Reductase 55% NoneNone NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) CITRININ Aldose Reductase 55% NoneNone NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) CITRININ Aldose Reductase 55% NoneNone NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) CITRININ Aldose Reductase 55% NoneNone NoneNone View
androgen receptor CORTISONE ACETATE Testosterone 55% NoneNone NoneNone View
dopamine receptor D4 BENZOTHIAZYL DISULFIDE Dopamine D4.2 55% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 BENZBROMARONE Cyclooxygenase COX-1 55% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) BENZBROMARONE Cyclooxygenase COX-1 55% NoneNone NoneNone View
mitogen activated protein kinase 3 FLUORESCEIN Protein Serine/Threonine Kinase, ERK1 55% NoneNone NoneNone View
mitogen-activated protein kinase 3 FLUORESCEIN Protein Serine/Threonine Kinase, ERK1 55% NoneNone NoneNone View
adrenergic receptor, alpha 2a DEXTROMETHORPHAN Adrenergic alpha2A 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel associated protein 1 DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel associated protein 2 DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) DOBUTAMINE Protein Tyrosine Kinase, HER2 Receptor 55% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) DOBUTAMINE Protein Tyrosine Kinase, HER2 Receptor 55% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit GENTIAN VIOLET Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit GENTIAN VIOLET Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit GENTIAN VIOLET Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit GENTIAN VIOLET Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit GENTIAN VIOLET Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit GENTIAN VIOLET Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit GENTIAN VIOLET Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit GENTIAN VIOLET Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit GENTIAN VIOLET Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 GENTIAN VIOLET Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
adrenergic receptor, beta 3 BROMOCRIPTINE Adrenergic beta3 57% NoneNone NoneNone View
dopamine receptor 2 MIANSERIN Dopamine D2L 57% NoneNone NoneNone View
melanocortin 5 receptor LOPERAMIDE Melanocortin MC5 57% NoneNone NoneNone View
dopamine receptor D3 LORATADINE Dopamine D3 57% NoneNone NoneNone View
Cytochrom P450-2E1 monooxygenase 1-NAPHTHYL ISOTHIOCYANATE CYP450-2E1 Inhibition 57% NoneNone NoneNone View
tachykinin receptor 2 LOPERAMIDE Tachykinin NK2 57% NoneNone NoneNone View
dopamine receptor D4 RISPERIDONE Dopamine D4.2 57% NoneNone NoneNone View
adrenergic receptor, alpha 2a IRINOTECAN Adrenergic alpha2A 57% NoneNone NoneNone View
adrenergic receptor, alpha 1a IMIQUIMOD Adrenergic alpha1A 57% NoneNone NoneNone View
tachykinin receptor 1 L-744832 Tachykinin NK1 57% NoneNone NoneNone View
adrenergic receptor, alpha 1b KETOTIFEN Adrenergic alpha1B 57% NoneNone NoneNone View
dopamine receptor 2 BOPINDOLOL Dopamine D2L 57% NoneNone NoneNone View
opioid receptor, sigma 1 NORTRIPTYLINE Sigma1 57% NoneNone NoneNone View
opioid receptor, kappa 1 CYPROTERONE ACETATE Opiate kappa 57% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit OLANZAPINE Calcium Channel Type L, Benzothiazepine 57% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel associated protein 1 AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel associated protein 2 AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha AMLODIPINE Sodium Channel, Site 2 57% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide OXYMETHOLONE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha OXYMETHOLONE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta OXYMETHOLONE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide OXYMETHOLONE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide OXYMETHOLONE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide OXYMETHOLONE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta OXYMETHOLONE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha OXYMETHOLONE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma OXYMETHOLONE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta OXYMETHOLONE Sodium Channel, Site 2 56% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit ERGOCORNINE Calcium Channel Type L, Phenylalkylamine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ERGOCORNINE Calcium Channel Type L, Phenylalkylamine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit ERGOCORNINE Calcium Channel Type L, Phenylalkylamine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit ERGOCORNINE Calcium Channel Type L, Phenylalkylamine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit ERGOCORNINE Calcium Channel Type L, Phenylalkylamine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 ERGOCORNINE Calcium Channel Type L, Phenylalkylamine 56% NoneNone NoneNone View
adrenergic receptor, alpha 2b AURANOFIN Adrenergic alpha2C 56% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) AURANOFIN Adrenergic alpha2C 56% NoneNone NoneNone View
dopamine receptor 2 AURANOFIN Dopamine D2L 56% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) DIETHYLSTILBESTROL CYP450-2C9 Inhibition 56% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 DIETHYLSTILBESTROL CYP450-2C9 Inhibition 56% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2D DIETHYLSTILBESTROL Glutamate, NMDA, Agonism 56% 28.066uM 25.393uM View
glutamate receptor, ionotropic, NMDA2C DIETHYLSTILBESTROL Glutamate, NMDA, Agonism 56% 28.066uM 25.393uM View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B DIETHYLSTILBESTROL Glutamate, NMDA, Agonism 56% 28.066uM 25.393uM View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A DIETHYLSTILBESTROL Glutamate, NMDA, Agonism 56% 28.066uM 25.393uM View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) DIETHYLSTILBESTROL Glutamate, NMDA, Agonism 56% 28.066uM 25.393uM View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B DIETHYLSTILBESTROL Glutamate, NMDA, Agonism 56% 28.066uM 25.393uM View
5-hydroxytryptamine (serotonin) receptor 2C DIETHYLSTILBESTROL Serotonin 5-HT2C 56% 50.819uM 26.619uM View
sodium channel, nonvoltage-gated 1, delta AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel associated protein 1 AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel associated protein 2 AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta AJMALINE Sodium Channel, Site 2 56% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) ACECLOFENAC Thromboxane Synthetase 55% NoneNone NoneNone View
phosphodiesterase 4A, cAMP specific OXAPROZIN Phosphodiesterase PDE4 55% NoneNone NoneNone View
phosphodiesterase 4C, cAMP-specific OXAPROZIN Phosphodiesterase PDE4 55% NoneNone NoneNone View
phosphodiesterase 4D OXAPROZIN Phosphodiesterase PDE4 55% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific OXAPROZIN Phosphodiesterase PDE4 55% NoneNone NoneNone View
opioid receptor, sigma 1 ONDANSETRON Sigma1 55% NoneNone NoneNone View
Sigma-2 Receptor ORPHENADRINE Sigma2 55% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PRIMAQUINE Calcium Channel Type L, Benzothiazepine 55% NoneNone NoneNone View
A3 adenosine receptor PROBUCOL Adenosine A3 55% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) BENZETHONIUM CHLORIDE Protein Tyrosine Kinase, Lck 55% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 ZAFIRLUKAST Adrenergic, Norepinephrine Transporter 55% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha DEXTROMETHORPHAN Sodium Channel, Site 2 55% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 FLUOXETINE Dopamine Transporter 55% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) CAPSAICIN CYP450-2C9 Inhibition 55% NoneNone NoneNone View